Abstract: The disclosure relates to modified apelin polypeptides having increased stability against kallikrein, NEP and ACE2 degradation and/or potency relative to the native apelin-13 and apelin-17 polypeptides. Embodiments also disclose methods of using the polypeptides for treating cardiovascular disorders.
Type:
Grant
Filed:
March 16, 2020
Date of Patent:
July 28, 2020
Assignee:
THE GOVERNERS OF THE UNIVERSITY OF ALBERTA
Inventors:
Gavin Oudit, John Vederas, Shaun McKinnie, Conrad Fischer
Abstract: Huntington's disease (HD) is a neurodegenerative disorder caused by the expansion of a polyglutamine stretch in the protein huntingtin (Htt). HD neurons are dysfunctional at multiple levels and have increased susceptibility to stress and apoptotic stimuli. As described therein there is provided compound(s), composition(s), methods and/or kits for the treatment and/or diagnosis of Huntington's disease.
Type:
Application
Filed:
August 20, 2010
Publication date:
November 8, 2012
Applicant:
THE GOVERNERS OF THE UNIVERSITY OF ALBERTA
Abstract: An atomic scale electroconductivity device with electrostatic regulation is provided that includes a perturbing species having a localized electronic charge ol a dangling bond. A sensing species having an electronic conductivity is placed in proximity to the perturbing species at a distance sufficient to induce a change in the electronic conductivity associated with the localized electronic charge. Electronics are provided to measure the conductivity via the sensing species. The dangling bond functions as a single atom gate electrode.
Type:
Grant
Filed:
March 8, 2006
Date of Patent:
December 13, 2011
Assignees:
The Governers of the University of Alberta, National Research Council of Canada
Inventors:
Robert A. Wolkow, Paul G. Piva, Jason L. Pitters, Gino A. Dilabio
Abstract: A bacterial ?1,3-fucosyltransferase gene and deduced amino acid sequence is provided. The gene is useful for preparing ?1,3-fucosyltransferase polypeptide, and active fragment thereof, which can be used in the production of oligosaccharides such as Lewis X, Lewis Y, and siayl Lewis X, which are structurally similar to certain tumor-associated carbohydrate antigens found in mammals. These product glycoconjugates also have research and diagnostic utility in the development of assays to detect mammalian tumors. In addition the polypeptide of the invention can be used to develop diagnostic and research assays to determine the presence of H. pylori in human specimens.
Type:
Grant
Filed:
July 3, 2002
Date of Patent:
November 8, 2005
Assignee:
The Governers of the University of Alberta
Abstract: A bacterial &agr;1,3-fucosyltransferase gene and deduced amino acid sequence is provided. The gene is useful for preparing &agr;1,3-fucosyltransferase polypeptide, and active fragment thereof, which can be used in the production of oligosaccharides such as Lewis X, Lewis Y, and siayl Lewis X, which are structurally similar to certain tumor-associated carbohydrate antigens found in mammals. These product glycoconjugates also have research and diagnostic utility in the development of assays to detect mammalian tumors. In addition the polypeptide of the invention can be used to develop diagnostic and research assays to determine the presence of H. pylori in human specimens.
Type:
Application
Filed:
December 7, 2000
Publication date:
June 6, 2002
Applicant:
The Governers of the University of Alberta, a Canada corporation
Abstract: A lean premixed fuel burner includes a peripheral ring stabilizer which divides the flow into a primary gas flow and a secondary gas flow and generates a secondary flame substantially surrounding the main flame formed by the main gas flow. Further stabilizers are provided in the area of the primary gas flow on the inside of the peripheral stabilizer. These stabilizers divide the main gas flow into a plurality of subsidiary flows whereby the primary flame is formed by a plurality of discrete flame formed in the spaces between the secondary stabilizers thereby to provide a main flame significantly shorter in the direction of gas flow than if a single primary flame is used.
Abstract: A novel reactor for reacting and subsequently analyzing sub-picomole quantities of a sample organic molecule. The reactor includes a continuous capillary connected between two valves that control fluid flow in the capillary. One part of the capillary forms a reaction chamber where the sample may be immobilized for subsequent reaction with reagents supplied through the valves. Another part of the capillary passes through or terminates in the detector portion of an analyzer such as an electrophoresis apparatus, liquid chromatographic apparatus or mass spectrometer. The apparatus may form a peptide or protein sequencer for carrying out the Edman degradation reaction and analyzing the reaction product produced by the reaction.